In a report released on March 19, Martin Roediger from Kepler Capital maintained a Hold rating on Evonik (0QDS – Research Report), with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback